創傷治療用生物製剤の世界市場:企業概要・規模・シェア・成長・動向・予測(~2025年)

【英語タイトル】Global Wound Care Biologics Market : Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Data Bridge Market Researchが出版した調査資料(DBMR810545)・商品コード:DBMR810545
・発行会社(調査会社):Data Bridge Market Research
・発行日:2018年8月
・ページ数:397
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Web Access)USD4,200 ⇒換算¥474,600見積依頼/購入/質問フォーム
Corporate UserUSD5,400 ⇒換算¥610,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Data Bridgeが出版した本調査レポートでは、創傷治療用生物製剤の世界市場について調査・分析し、創傷治療用生物製剤の世界市場動向、市場予測、セグメント別分析、創傷治療用生物製剤市場規模、関連企業分析などを含め以下の構成でお届けいたします。
【レポートの概要】

Global wound care biologics market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases aging population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for global wound care biologics s market are listed below:

• Smith and Nephew
• INTEGRA LIFE SCIENCES CORPORATION
• Mölnlycke Health Care AB
• Amnio Technology, LLC
• Alphatec Spine, Inc.
• BioHorizons IPH, Inc.
• ORGANOGENESIS INC
• CONVATEC AG
• Skye Biologics Inc.
• Anika Therapeutics, Inc.
• Osiris Therapeutics, Inc.
• Vericel Corporation
• MiMedx
• WRIGHT MEDICAL GROUP N.V.
• Kerecis
• ACell Inc.
• Solsys Medical
• Marine Polymer Technologies, Inc.
• Amniox Medical, Inc.
• Amniox Medical, Inc.

The global wound care biologics market is segmented into:
• Product Type
• Wound Type
• End User

On the basis of product type the global wound care biologics market is segmented into synthetic skin grafts, growth factors, allografts, xenografts. In 2018, synthetic skin grafts segment is expected to dominate the Global wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF)segment, platelet rich plasma (PRP)segment, epidermal growth factor (EGF)segment and basic fibroblast growth factor (BFGF)segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa, thrombin peptide (TP508)segment, keratinocyte growth factor (KGF)segment.
On the basis of wound type the global wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segmentis expected to dominate the global wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.
On the basis of end user the global wound care biologics s market is segmented into hospitals, wound care centres and ambulatory centers, clinics, community healthcare centers. In 2018, hospitals are expected to dominate the global wound care biologics market with the highest market shares in the forecast period 2018 to 2025.
Based on geography, the market is segmented into 5 geographical regions:
• Europe
• North America
• Asia-Pacific
• South America
• Middle East & Africa
Covered in this report
The report covers the present scenario and the growth prospects of the global wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table Of Contents
1 Introduction 31
1.1 Objectives Of The Study 31
1.2 Market Definition 31
1.3 Overview Of Global Wound Care Biologics Market 31
1.4 Currency And Pricing 32
1.5 Limitation 32
1.6 Markets Covered 33
2 Market Segmentation 35
2.1 Markets Covered 35
2.2 Geographic Scope 36
2.3 Years Considered For The Study 37
2.4 Currency And Pricing 37
2.5 Research Methodology 38
2.6 Primary Interviews With Key Opinion Leaders 41
2.1 Dbmr Market Position Grid 42
2.2 Dbmr Market Challenge Matrix 43
2.3 Secondary Sources 44
2.4 Assumptions 44
3 Market Overview 45
3.1 Drivers 47
3.1.1 Increasing Cases Of Diabetic Foot Ulcers 47
3.1.2 Increasing Incidences Of Burn Cases 47
3.1.3 Rising Number Of Geriatric Population 48
3.1.4 Innovation In Wound Care Biologics 49
3.1.5 New Product Launches 51
3.2 Restrains 51
3.2.1 High Cost Of Wound Treatment And Wound Care Biologics 51
3.2.2 Risk Of Skin Substitue Failure 52
3.3 Opportunities 53
3.3.1 3D Skin Printing 53
3.3.2 Awareness Programs 54
3.4 Challenges 55
3.4.1 Lack Of Wound Management Services 55
4 Executive Summary 56
5 Premium Insights 60
6 Global Wound Care Biologics Market, By Product Type 65
6.1 Overview 66
6.2 Synthetic Skin Grafts 68
6.3 Growth Factors 69
6.3.1 Platelet Derived Growth Factor (Pdgf) 72
6.3.2 Platelet Rich Plasma (Prp) 72
6.3.3 Epidermal Growth Factors (Egf) 72
6.3.4 Basic Fibroblast Growth Factors (Bfgf) 73
6.3.5 Granulocyte Colony Stimulating Factor (G-Csf) 73
6.3.6 Talactoferrin Alfa 73
6.3.7 Thrombin Peptide 74
6.3.8 Keratinocy Growth Factor (Kgf) 74
6.4 Allografts 75
6.5 Xenografts 76
7 Global Wound Care Biologics Market, By Wound Type 78
7.1 Overview 79
7.2 Wounds 80
7.2.1 Surgical Wound 82
7.2.1.1 Skin Surgery 83
7.2.1.1.1 Wound Closure 84
7.2.1.1.2 Skin Biopsy 84
7.2.1.1.3 Skin Flap 84
7.2.1.1.4 Skin Graft 84
7.2.1.1.5 Others 84
7.2.1.2 Cosmetic Procedure 85
7.2.1.2.1 Brest Enhancement 86
7.2.1.2.2 Facial Contouring 87
7.2.1.2.3 Facial Rejuvenation: 87
7.2.1.2.4 Body Contouring 87
7.2.1.2.5 Skin Rejuvenation 87
7.2.1.2.6 Others 88
7.2.1.3 Gynecologic Procedures 88
7.2.1.3.1 Pubovaginalis Sling 88
7.2.1.3.2 Pelvic Floor Reconstruction 89
7.2.1.3.3 Rectocele Repair Surgery 89
7.2.1.3.4 Others 89
7.2.1.4 Gastrointestinal Procedure 89
7.2.1.4.1 General Gastrointestinal Surgery 90
7.2.1.4.2 Hernia 91
7.2.1.4.3 Others 91
7.2.2 Acute Wounds 92
7.2.3 Chronic Wounds 92
7.2.4 Traumatic Wounds 93
7.3 Burns 93
7.3.1 Ulcers 94
7.3.2 Diabetic Ulcers 96
7.3.3 Pressure Ulcer 96
7.3.4 Venous Ulcer 97
7.3.5 Others 97
8 Global Wound Care Biologics Market, By End User 98
8.1 Overview 99
8.2 Hospitals 101
8.3 Wound Care Centers 102
8.4 Ambulatory Surgical Centers 103
8.5 Clinics 105
8.6 Community Healthcare Center 106
9 Global Wound Care Biologics Market: Geography 107
9.1 Global 107
9.2 North America 114
9.2.1 U.S. 125
9.2.2 Canada 132
9.2.3 Mexico 139
9.3 Europe 146
9.3.1 Germany 158
9.3.2 France 165
9.3.3 U.K. 172
9.3.4 Italy 179
9.3.5 Switzerland 186
9.3.6 Netherlands 193
9.3.7 Russia 201
9.3.8 Turkey 208
9.3.9 Spain 215
9.3.10 Belgium 222
9.3.11 Rest Of Europe 229
9.4 Asia-Pacific 230
9.4.1 China 242
9.4.2 Japan 249
9.4.3 India 256
9.4.4 South Korea 263
9.4.5 Australia 270
9.4.6 Thailand 277
9.4.7 Malaysia 284
9.4.8 Singapore 291
9.4.9 Indonesia 298
9.4.10 Philippines 305
9.4.11 Rest Of Asia-Pacific 312
9.5 South America 313
9.5.1 Brazil 324
9.5.2 Rest Of South America 331
9.6 Middle East & Africa 332
9.6.1 South Africa 343
9.6.2 Rest Of Middle East & Africa 350
10 Global Wound Care Biologics Market, Company Landscape 351
10.1 Company Share Analysis: Global 351
10.2 Company Share Analysis: North America 352
10.3 Company Share Analysis: Europe 353
10.4 Company Share Analysis: Asia-Pacific 354
11 Company Profile 355
11.1 Mimedx. 355
11.1.1 Company Overview 355
11.1.2 Revenue Analysis: 355
11.1.3 Company Share Analysis: 356
11.1.4 Product Portfolio 356
11.1.5 Recent Developments 357
11.2 Organogenesis Inc 358
11.2.1 Company Overview 358
11.2.2 Geographic Presence 358
11.2.3 Company Share Analysis: 359
11.2.4 Product Portfolio 359
11.2.5 Recent Developments 360
11.3 Integra Lifesciences 361
11.3.1 Company Overview 361
11.3.2 Revenue Analysis 361
11.3.3 Company Share Analysis: 362
11.3.4 Product Portfolio 362
11.3.5 Recent Developments 363
11.4 Convatec Inc. 364
11.4.1 Company Overview 364
11.4.2 Revenue Analysis 364
11.4.3 Company Share Analysis: 365
11.4.4 Product Portfolio : 365
11.4.5 Recent Developments 365
11.5 Acell Inc. 366
11.5.1 Company Overview 366
11.5.2 Product Portfolio 366
11.5.3 Recent Developments 367
11.6 Allosource 368
11.6.1 Company Overview 368
11.6.2 Product Portfolio 368
11.6.3 Recent Developments 369
11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc) 370
11.7.1 Company Overview 370
11.7.2 Product Portfolio 370
11.7.3 Recent Developments 370
11.8 Amnio Technology, Llc 371
11.8.1 Company Overview 371
11.8.2 Product Portfolio 371
11.8.3 Recent Developments 372
11.9 Amniox Medical, Inc. 373
11.9.1 Company Overview 373
11.9.2 Product Portfolio 373
11.9.3 Recent Developments 374
11.10 Anika Therapeutics, Inc. 375
11.10.1 Company Overview 375
11.10.2 Revenue Analysis 375
11.10.3 Product Portfolio 376
11.10.4 Recent Developments 376
11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.) 377
11.11.1 Company Overview 377
11.11.2 Geographicpresence 377
11.11.3 Product Portfolio 378
11.11.4 Recent Developments 378
11.12 Kerecis 379
11.12.1 Company Overview 379
11.12.2 Geographical Presence 379
11.12.3 Product Portfolio 380
11.12.4 Recent Developments 380
11.13 Marine Polymer Technologies, Inc 381
11.13.1 Company Overview 381
11.13.2 Product Portfolio 381
11.13.3 Recent Developments 381
11.14 Mölnlycke Health Care Ab 382
11.14.1 Company Overview 382
11.14.2 Revenue Analysis 382
11.14.3 Product Portfolio 383
11.14.4 Recent Developments 383
11.15 Osiris Therapeutics, Inc. 384
11.15.1 Company Overview 384
11.15.2 Revenue Analysis 384
11.15.3 Product Portfolio 385
11.15.4 Recent Developments 385
11.16 Skye Biologics Inc. 386
11.16.1 Company Overview 386
11.16.2 Product Portfolio : 386
11.16.3 Recent Development: 387
11.17 Smith And Nephew 388
11.17.1 Company Overview 388
11.17.2 Revenue Analysis 388
11.17.3 Product Portfolio 389
11.17.4 Recent Developments 389
11.18 Solsys Medical. 390
11.18.1 Company Overview 390
11.18.2 Product Portfolio 391
11.18.3 Recent Developments 391
11.19 Vericel Corporation. 392
11.19.1 Company Overview 392
11.19.2 1.1.2 Revenue Analysis 392
11.19.3 Product Portfolio 393
11.19.4 Recent Developments 393
11.20 Wright Medical Group N.V 394
11.20.1 Company Overview 394
11.20.2 1.1.2 Revenue Analysis 394
11.20.3 Product Portfolio 395
11.20.4 Recent Developments 396
12 Related Reports 397

...

【レポートのキーワード】

創傷治療用生物製剤

★調査レポート[創傷治療用生物製剤の世界市場:企業概要・規模・シェア・成長・動向・予測(~2025年)] (コード:DBMR810545)販売に関する免責事項を必ずご確認ください。
★調査レポート[創傷治療用生物製剤の世界市場:企業概要・規模・シェア・成長・動向・予測(~2025年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆